119 related articles for article (PubMed ID: 11799032)
1. Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit.
Kirwan JM; Tincello DG; Herod JJ; Frost O; Kingston RE
BMJ; 2002 Jan; 324(7330):148-51. PubMed ID: 11799032
[TBL] [Abstract][Full Text] [Related]
2. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
3. Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis.
Nitecki R; Diver EJ; Kamdar MM; Boruta DM; Del Carmen MC; Clark RM; Goodman A; Schorge JO; Growdon WB
Gynecol Oncol; 2018 Mar; 148(3):521-526. PubMed ID: 29395315
[TBL] [Abstract][Full Text] [Related]
4. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey.
Fagö-Olsen CL; Høgdall C; Kehlet H; Christensen IJ; Ottesen B
Acta Obstet Gynecol Scand; 2011 Mar; 90(3):273-9. PubMed ID: 21306310
[TBL] [Abstract][Full Text] [Related]
5. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer.
Richards MA; Smith P; Ramirez AJ; Fentiman IS; Rubens RD
Br J Cancer; 1999 Feb; 79(5-6):858-64. PubMed ID: 10070881
[TBL] [Abstract][Full Text] [Related]
6. What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?
Woodman C; Baghdady A; Collins S; Clyma JA
Br J Obstet Gynaecol; 1997 Feb; 104(2):135-9. PubMed ID: 9070126
[TBL] [Abstract][Full Text] [Related]
7. Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study.
Tracey E; Hacker NF; Young J; Armstrong BK
Int J Gynecol Cancer; 2014 Sep; 24(7):1232-40. PubMed ID: 25153678
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and survival after surgery for ovarian cancer.
Eeles RA; Tan S; Wiltshaw E; Fryatt I; A'Hern RP; Shepherd JH; Harmer CL; Blake PR; Chilvers CE
BMJ; 1991 Feb; 302(6771):259-62. PubMed ID: 1998789
[TBL] [Abstract][Full Text] [Related]
9. Delays in presentation and management of ovarian cancer in Lagos, Nigeria.
Rabiu KA; Akinola OI; Adewunmi AA; Fabamwo AO; Adedeji MO; Popoola AO
J Obstet Gynaecol; 2013 Apr; 33(3):305-8. PubMed ID: 23550866
[TBL] [Abstract][Full Text] [Related]
10. National guidance on gynaecological cancer management: an audit of gynaecological cancer services and management in the South East of England.
Shaw M; Wolfe C; Raju KS; Papadopoulos A
Eur J Gynaecol Oncol; 2003; 24(3-4):246-50. PubMed ID: 12807233
[TBL] [Abstract][Full Text] [Related]
11. Minimizing delays in ovarian cancer diagnosis: an expansion of Andersen's model of 'total patient delay'.
Evans J; Ziebland S; McPherson A
Fam Pract; 2007 Feb; 24(1):48-55. PubMed ID: 17158183
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.
Eskander RN; Carpenter BA; Wu HG; Wolf JK
Curr Med Res Opin; 2016 Jun; 32(6):1161-5. PubMed ID: 27052730
[TBL] [Abstract][Full Text] [Related]
14. Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes.
Neal RD; Allgar VL; Ali N; Leese B; Heywood P; Proctor G; Evans J
Br J Gen Pract; 2007 Mar; 57(536):212-9. PubMed ID: 17359608
[TBL] [Abstract][Full Text] [Related]
15. A survey of open-access endoscopy in primary health care centres: outcome of gastric carcinoma patients diagnosed by general practitioners compared with hospital-referred endoscopy.
Voutilainen M; Kunnamo I
Dig Liver Dis; 2005 Feb; 37(2):119-23. PubMed ID: 15733525
[TBL] [Abstract][Full Text] [Related]
16. Delays in referral from primary care worsen survival for patients with colorectal cancer: a retrospective cohort study.
Arhi CS; Burns EM; Bottle A; Bouras G; Aylin P; Ziprin P; Darzi A
Br J Gen Pract; 2020 Jul; 70(696):e463-e471. PubMed ID: 32540874
[TBL] [Abstract][Full Text] [Related]
17. Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines.
Shylasree TS; Howells RE; Lim K; Jones PW; Fiander A; Adams M; Evans AS;
Int J Gynecol Cancer; 2006; 16(5):1770-6. PubMed ID: 17009970
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
19. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
[TBL] [Abstract][Full Text] [Related]
20. Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?
Barakat A; Ismail A; Davies Q; Chattopadhyay S
In Vivo; 2022; 36(4):1834-1840. PubMed ID: 35738607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
